Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency symptoms

LUTS: Lower Urinary Tract Symptoms

Volumn 2, Issue 2, 2010, Pages 88-94

  Kuo, Hann Chorng ^a   Liu, Hsin Tzu ^a   Tyagi, Pradeep ^b   Chancellor, Michael B ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Lower urinary tract disease; Nerve growth factor; Overactive bladder

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; NERVE GROWTH FACTOR; TOLTERODINE;

ACUTE BACTERIAL CYSTITIS; ARTICLE; BLADDER TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFICACY; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PAINFUL BLADDER SYNDROME; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY FREQUENCY; URINARY TRACT DISEASE; URINARY URGENCY; UROLITHIASIS;

EID: 79951907508     PISSN: 17575664     EISSN: 17575672     Source Type: Journal    
DOI: 10.1111/j.1757-5672.2010.00065.x     Document Type: Article

References (23)

1. Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 2000; 161: 273-84.
2. Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 1999; 57: 583-606.
3. Vizzard MA. Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury. Prog Brain Res 2006; 152: 97-115.
4. Seki S, Sasaki K, Igawa Y et al. Detrusor overactivity induced by increased levels of nerve growth factor in bladder afferent pathways in rats. Neurourol Urodyn 2003; 22: 375-7.
5. Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004; 5: 150-6.
6. Yoshimura N, Bennett NE, Hayashi Y et al. Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci 2006; 26: 10847-55.
7. Zvara P, Vizzard MA. Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol 2007; 7: 1-11.
8. Steers WD, Kolbeck S, Creedon D, Tuttle JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991; 88: 1709-15.
9. Liu HT, Kuo HC. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Urology 2008; 72: 104-8.
10. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997; 79: 572-7.
11. Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007; 70: 463-8.
12. Kim JC, Park EY, Seo SI, Park YH, Hwang TK. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006; 175: 1773-6.
13. Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 2009; 56: 700-6.
14. Liu HT, Kuo HC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 2008; 179: 2270-4.
15. Liu HT, Tyap P, Chancellor MB, Kuo HC. Urinary nerve growth factor level is increased in patients with interstitial cystitis/painful bladder syndrome and decreased in responders to treatment. BJU Int 2009; 104: 1476-81.
16. Liu HT, Kuo HC. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodyn 2009; 28: 78-81.
17. Liu HT, Chancellor MB, Kuo HC. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 2009; 103: 1668-72.
18. Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women. BJU Int 2008; 102: 1440-4.
19. Okragly AJ, Niles AL, Saban R et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 1999; 161: 438-42.
20. Yokoyama T, Kumon H, Nagai A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn 2008; 27: 417-20.
21. Kim JC, Kim JH, Lee JY et al. Changes of urinary nerve growth factor and prostaglandin E2 after anticholinergic treatment in female patients with overactive bladder. ICS 2008; abstract 50.
22. Dmitrieva N, Shelton D, Rice AS, McMahon SB. The role of nerve growth factor in a model of visceral inflammation. Neuroscience 1997; 78: 449-59.
23. Steers WD, Tuttle JB. Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006; 3: 101-10.